Menu Search
Equities

Vijaya Diagnostic Centre Ltd

VIJAYA:NSI

Vijaya Diagnostic Centre Ltd

Actions
Health CareMedical Equipment and Services
  • Price (INR)1,038.20
  • Today's Change17.20 / 1.68%
  • Shares traded268.33k
  • 1 Year change+68.02%
  • Beta--
Data delayed at least 15 minutes, as of Nov 14 2024 10:19 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 16-Nov-23
  • 15-Aug-24
  • 19-Sep-24
  • 17-Oct-24
  • 07-Nov-24
Select bar for recommendation details.
Recommendations07-Nov-24
Buy2
Outperform2
Hold3
Sell0
Strong Sell0

Share price forecast in INR

The 7 analysts offering 12 month price targets for Vijaya Diagnostic Centre Ltd have a median target of 1,100.00, with a high estimate of 1,237.00 and a low estimate of 660.00. The median estimate represents a 5.73% increase from the last price of 1,040.35.
High18.9%1,237.00
Med5.7%1,100.00
Low-36.6%660.00

Dividends

In 2024, Vijaya Diagnostic Centre Ltd reported a dividend of 1.00 INR, equaling last years dividend. The 5 analysts covering the company expect dividends of 1.62 INR for the upcoming fiscal year, an increase of 62.00%.
Div growth (TTM)0.00%
More ▼

Earnings history & estimates in INR

On May 08, 2024, earnings of 3.26 per share. This result exceeded the 3.00 expectation of the one analyst covering the company
The next earnings announcement is expected on May 26, 2025.
Average growth rate+14.82%
Vijaya Diagnostic Centre Ltd reported annual 2024 earnings of 11.79 per share on May 08, 2024.
Average growth rate+10.00%
More ▼

Revenue history & estimates in INR

Vijaya Diagnostic Centre Ltd had 2nd quarter 2025 revenues of 1.83bn. This bettered the 1.73bn consensus of the 4 analysts covering the company. This was 51.13% above the prior year's 2nd quarter results.
Average growth rate+7.57%
Vijaya Diagnostic Centre Ltd had revenues for the full year 2024 of 5.48bn. This was 19.29% above the prior year's results.
Average growth rate+9.30%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.